“…The 17 studies that were reviewed based on the eligibility criteria varied in design (Table S2). Ten studies were randomized controlled trials [21,25,40,41,42,43,44,45,46,47], one was a randomized crossover trial [48], two studies were randomized pilot studies [49,50], two were quasi-experimental studies [20,51], and there was one of each of the following designs—a prospective cohort study [24] and a case control study [52]. The studies were also diverse in geographical locations, which included (Table S2): New Zealand ( n = 2) [21,50], United States of America ( n = 2) [47,49], Iran ( n = 2) [44,46], Germany ( n = 3) [40,42,48], The Netherlands ( n = 2) [20,52], Australia ( n = 1) [25], Belgium ( n = 1) [41], England ( n = 1) [43], Scotland ( n = 1) [51], Turkey ( n = 1) [24], and Sweden ( n = 1) [45].…”